Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone in the Early Management of Acute Coronary Syndrome: Randomised Controlled Study

NCT00965406 Phase 3 COMPLETED

The aim of this study is to evaluate the effect of the glucose insulin potassium (GIK) infusion associated with intensive insulin therapy compared to GIK alone and control group in patients presenting to the ED with acute coronary syndrome.

Details

Lead sponsor	University of Monastir
Phase	Phase 3
Status	COMPLETED
Enrolment	772
Start date	2010-08
Completion	2014-06

Conditions

• Acute Coronary Syndrome

Interventions

• GIK and intensive insulin therapy

Primary outcomes

• 30 days mortality, reinfarction, urgent coronary revascularisation, and stroke. — 24 hours

Countries

Tunisia